Company intelligence / Profile preview

Biomedis Technologies Co.

Russia (implied from certifications)

Ownership: Private
Development stage: Other

Overview

BIOMEDIS develops and sells high-tech products aimed at health maintenance and recovery. Their products are certified by regulatory bodies in the EU, USA, Russia, and CIS countries. The company claims a user base of 50,000 across 18 countries with 15,000 partners[3].

Therapeutic areas: Other
Modalities: High technology products for health maintenance and recovery; specific therapeutic modalities not detailed in available sources[1][2][3].
Industry: Physiological Monitoring

Partnerships

Not specified

Beyond the preview

Go deeper on Biomedis Technologies Co..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomedis Technologies Co..

Explore the full profile